Schedule 13G ownership disclosure

GW PHARMACEUTICALS PLC

Security class unavailable · CUSIP: G4210C104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
31,371,425
Percent of class
13.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000922898-15-000012
Form type
SC 13G
Filer
GW PHARMACEUTICALS PLC
CIK
CIK 1351288
Filed
Feb 04, 2015
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub